24/7 WALL STREET
Tilray aims for $1.5-billion valuation ahead of planned Nasdaq IPO
Marijuana Stocks: Tilray Set To Become First U.S. Marijuana IPO
INVESTOR’S BUSINESS DAILY
This year, the first two straight-up marijuana stocks joined the New York Stock Exchange and the Nasdaq.
Tilray Inc. Launches Initial Public Offering
Tilray Inc. announced it has launched an IPO of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission.
Tilray Inc. Announces Filing of a U.S. Registration Statement and Application for Proposed IPO on Nasdaq
Tilray Inc., a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, today
Big Pharma's first foray into cannabis arrives with Sandoz-Tilray deal
FINANCIAL POST
The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.
Cannabis producer Tilray taps private equity funding
THE GLOBE AND MAIL
Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.
CBC: Canadian producers set sights on global domination
CBC NEWS
Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. That's led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.
CEO Brendan Kennedy appears on CBC's "On the Money"
CBC NEWS
Tilray Chief Executive Officer Brendan Kennedy discusses Tilray's Portugal expansion with CBC Business News.
Tilray featured in The New York Times
THE NEW YORK TIMES
Tilray CEO Brendan Kennedy shared his insights about Canada's history-making effort to legalize and regulate adult-use cannabis.
Medical cannabis helps my son lead a more normal life
SHEKNOWS MEDIA
Discovering that CBD was an undeveloped potential anticonvulsant that might help thousands of children changed the course of my career. I’m now the clinical research director for Tilray, a medical cannabis company that provides patients with access to safe, reliable and consistent products to treat a wide variety of ailments.
Medical marijuana growers push for cannabis oil coverage for veterans
THE GLOBE AND MAIL
Despite a Supreme Court of Canada decision that gives sick Canadians the right to use medical cannabis oils, Ottawa is reimbursing the country’s veterans for dried pot only, potentially pushing them to less healthy options of smoking or vaporizing the drug. Mr. Lucas, also head of patient services at Nanaimo-based grower Tilray, recently launched an e-petition sponsored by his local MP, New Democrat Sheila Malcolmson, asking Veterans Affairs to begin covering these extracts.
Medical marijuana research comes out of the shadows
PBS NEWSHOUR
PBS speaks to neuroscientist Catherine Jacobson, who heads clinical research for Tilray, about how the company is trying to turn cannabis into conventional medicine.
Tilray ships medical marijuana to Croatia
BUSINESS NEWS NETWORK
Tilray, a Canadian cannabis producer, recently announced that it received approval to ship two varieties of liquid capsules to Croatia. Brendan Kennedy, Global President with Tilray says that Europe presents a good growth opportunity for Tilray.
Tilray begins exporting medical marijuana to Croatia
CBC NEWS
Canadian cannabis producer Tilray is placing its bets on budding demand from markets overseas as it begins shipping medical marijuana products to Croatia.
A Canadian Company Just Became the First to Legally Export Medical Cannabis to Europe
VICE NEWS
Tilray, based in British Columbia and one of the companies licensed by Canada's federal health ministry to produce and distribute medical cannabis, was recently granted an export permit. It's believed to be the first time a North American company has legally exported cannabis to the EU for commercial medical use.
Research director Catherine Jacobson appears on SiriusXM radio show
WHAT SHE SAID RADIO (SIRIUSXM)
There are still far too many myths and misconceptions surrounding medical cannabis. On Tuesday, Dr. Catherine Jacobson, the Director of Clinical Research at Tilray, appeared on What She Said Radio to debunk those myths and answer some frequently asked questions.
Five questions with Tilray, B.C.'s largest licensed medical pot producer
CTV VANCOUVER ISLAND
Tilray, one of Canada's largest medical marijuana producers, has opened the doors of its 65,000-square-foot, $30-million Nanaimo facility to give a rare glimpse of its production process. Company CEO Greg Engel answers five questions about the facility, its employees, legalization, and lessons for the industry.
Canada to introduce legislation in 2017 to legalize sale of marijuana
WASHINGTON POST
Brendan Kennedy, president of Privateer Holdings of Seattle, welcomed the Canadian announcement. His company owns Tilray, a medicinal marijuana facility in British Columbia, and he is looking to build a facility that would supply the market for recreational marijuana in Canada.
Cannabis helps my epileptic son. If only we had known sooner.
THE GUARDIAN
As a mother, I am furious that the federal government has discouraged research into these potentially life-saving therapies for years by restricting clinical research. As a scientist, I decry the federal government for interfering with scientific freedom.